InhaleRx Past Earnings Performance
Past criteria checks 0/6
InhaleRx's earnings have been declining at an average annual rate of -0.1%, while the Medical Equipment industry saw earnings growing at 5.6% annually. Revenues have been growing at an average rate of 37% per year.
Key information
-0.1%
Earnings growth rate
24.5%
EPS growth rate
| Medical Equipment Industry Growth | 5.8% |
| Revenue growth rate | 37.0% |
| Return on equity | -216.9% |
| Net Margin | -119.9% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How InhaleRx makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 1 | -1 | 1 | 1 |
| 30 Sep 23 | 1 | -2 | 1 | 2 |
| 30 Jun 23 | 0 | -2 | 1 | 2 |
| 31 Mar 23 | 0 | -2 | 1 | 1 |
| 31 Dec 22 | 0 | -2 | 1 | 1 |
| 30 Sep 22 | 0 | -2 | 1 | 1 |
| 30 Jun 22 | 0 | -1 | 1 | 1 |
| 31 Mar 22 | 0 | -1 | 1 | 0 |
| 31 Dec 21 | 0 | -1 | 1 | 0 |
| 30 Sep 21 | 0 | -1 | 1 | 0 |
| 30 Jun 21 | 0 | -1 | 1 | 0 |
| 31 Mar 21 | 0 | -1 | 1 | 0 |
| 31 Dec 20 | 0 | -1 | 1 | 0 |
| 30 Sep 20 | 0 | -2 | 1 | 0 |
| 30 Jun 20 | 0 | -2 | 1 | 0 |
| 31 Mar 20 | 0 | -2 | 1 | 0 |
| 31 Dec 19 | 0 | -2 | 2 | 0 |
| 30 Sep 19 | 0 | -2 | 2 | 0 |
| 30 Jun 19 | 0 | -2 | 2 | 0 |
| 31 Mar 19 | 0 | -2 | 2 | 0 |
| 31 Dec 18 | 0 | -2 | 2 | 0 |
| 30 Sep 18 | 0 | -2 | 2 | 0 |
| 30 Jun 18 | 1 | -2 | 2 | 0 |
| 31 Mar 18 | 1 | -3 | 2 | 0 |
| 31 Dec 17 | 0 | -3 | 3 | 0 |
| 31 Dec 16 | 0 | 0 | 0 | 0 |
Quality Earnings: IRX is currently unprofitable.
Growing Profit Margin: IRX is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: IRX is unprofitable, and losses have increased over the past 5 years at a rate of 0.1% per year.
Accelerating Growth: Unable to compare IRX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: IRX is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.1%).
Return on Equity
High ROE: IRX has a negative Return on Equity (-216.88%), as it is currently unprofitable.